Memorial University of Newfoundland, St John's, NL, Canada.
School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, ON, Canada.
JMIR Mhealth Uhealth. 2019 Jun 10;7(6):e13950. doi: 10.2196/13950.
Using a mobile health (mHealth) intervention, consisting of a smartphone and compatible medical device, has the potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes while mitigating health care costs.
The aim of this study was to explore the potential facilitators and barriers among health care providers (HCPs) regarding the use of mHealth interventions for COPD management.
This was a qualitative study. Semistructured individual interviews were conducted with HCPs, including nurses, pharmacists, and physicians who work directly with patients with COPD. A flexible prompts guide was used to facilitate discussions. Interview topics included the following: demographics, mHealth usage, perceptions toward challenges of mHealth adoption, factors facilitating mHealth adoption, and preferences regarding features of the mHealth intervention for COPD management. Interviews were conversational in nature, and items were not asked verbatim or in the order presented. The interviews were transcribed verbatim and compared against the digital recordings to ensure the accuracy of the content. After creating a codebook for analysis, 2 researchers independently coded the remaining interview data using pattern coding. They discussed commonalities and differences in coding until a consensus was reached.
A total of 30 nurses, physicians, and pharmacists participated. The main facilitators to mHealth adoption are possible health benefits for patients, ease of use, educating patients and their HCPs, credibility, and reducing cost to the health care system. Alternatively, the barriers to adoption are technical issues, privacy and confidentiality issues, lack of awareness, potential limited uptake from the elderly, potential limited connection between patients and HCPs, and finances.
It is important to understand the perceptions of HCPs regarding the adoption of innovative mHealth interventions for COPD management. This study identifies some potential facilitators and barriers that may inform the successful development and implementation of mHealth interventions for COPD management.
使用移动医疗 (mHealth) 干预措施,包括智能手机和兼容的医疗设备,有可能改善慢性阻塞性肺疾病 (COPD) 的治疗效果,同时降低医疗成本。
本研究旨在探讨医疗保健提供者 (HCP) 在 COPD 管理中使用 mHealth 干预措施的潜在促进因素和障碍。
这是一项定性研究。对直接与 COPD 患者合作的护士、药剂师和医生等 HCP 进行了半结构式个人访谈。使用灵活的提示指南来促进讨论。访谈主题包括:人口统计学、mHealth 使用情况、对 mHealth 采用挑战的看法、促进 mHealth 采用的因素以及对 COPD 管理 mHealth 干预措施的功能偏好。访谈的性质是对话式的,并非逐字或按呈现顺序提问。访谈内容逐字转录,并与数字录音进行比较,以确保内容的准确性。在创建分析代码本后,两名研究人员使用模式编码独立对其余访谈数据进行编码。他们讨论了编码的共同点和差异,直到达成共识。
共有 30 名护士、医生和药剂师参与。mHealth 采用的主要促进因素是患者可能获得的健康益处、易于使用、教育患者及其 HCP、可信度以及降低医疗保健系统的成本。相反,采用的障碍是技术问题、隐私和保密问题、缺乏意识、老年人的潜在采用率有限、患者与 HCP 之间的潜在联系有限,以及财务问题。
了解 HCP 对 COPD 管理中采用创新 mHealth 干预措施的看法非常重要。本研究确定了一些潜在的促进因素和障碍,可能为成功开发和实施 COPD 管理的 mHealth 干预措施提供信息。